Hikma Pharmaceuticals

From Wikipedia, the free encyclopedia


Hikma Pharmaceuticals
Type Public (LSE: HIK)
Founded Amman, Jordan (1978)
Headquarters London, UK
Key people Samih Darwazah Chairman
Said Darwazah CEO
Taghreed Al-Shunnar VP
Industry Pharmaceutical
Products Amoclan
Prograf
Suprax
Revenue $317 million (2006)
Employees 2,000 (2006)
Website www.hikma.com

Hikma Pharmaceuticals (LSE: HIK) is a multinational pharmaceutical company based in London, that manufactures branded/non-branded generic and in-licensed pharmaceutical products. The firm was founded in Amman, Jordan in 1978 by Samih Darwazah.
In August 1996, Hikma Pharmaceuticals became the first Arab company to export pharmaceutical products to the United States[1].
Hikma shows strong presence in the Middle East & North Africa region, the United States and Europe.

Contents

[edit] Production Facilities

located in :

  • USA (FDA Approval).
  • Portugal (FDA Approval).
  • Italy.
  • Jordan (FDA & MHRA Approval).
  • Saudi Arabia (FDA Approval).
  • Algeria.
  • Germany.
  • Egypt.

[edit] Acquisitions

[edit] Products

Allopurinol , Alprazolam , Amoxicillin , Amoxicillin/Clavulanic Acid , Atenolol , Atenolol / Chlortalidone , Atorvastatin , Azithromycin , Bromocriptine , Carvedilol , Cefadroxil , Cefalexin , Cefdinir , Cefixime , Chlordiazepoxide , Ciprofloxacin , Clarithromycin , Diclofenac , Doxazosin , Erdosteine , Famotidine , Fluconazole , Flutrimazole , Gabapentin , Gemifloxacin , Glibenclamide , Glimepiride , Hydrocortisone , Ibuprofen , Imidapril , Indometacin , Iron Ferrous , Isoconazole , Isoconazole / Diflucortolone , Ketotifen , Lisinopril , Loratadine , Lornoxicam , Mefenamic Acid , Metronidazole , Micafungin , Naproxen , Norethisterone , Omeprazole , Paracetamol , Pseudoephedrine/Triprolidine , Ranitidine , Risperdone , Sertraline , Tacrolimus , Terbinafine


[edit] Notes

  1. ^ Economy - Sectoral Analysis

[edit] External links